Interestingly, the selective activation of intestinal FXR appears to have a protective role, restricting abnormal growth of Lgr5+ cells and potentially curtailing the progression of colorectal cancer (CRC) [34]. This evidence concerns the gene LGR5 and colorectal cancer.